ArchiMed has invested in plasmid DNA and protein therapeutics developer Xpress Biologics, with the intention of implementing a tenfold production capacity increase for the company.
ArchiMed has invested in plasmid DNA and protein therapeutics developer Xpress Biologics, with the intention of implementing a tenfold production capacity increase for the company.